Oct 23, 2018
Blog
All News
Oct 22, 2018
Blog
Emerging Biotech Company Looking to Raise Money? Start by Raising Your Visibility
By ICR Healthcare
Oct 10, 2018
Blog
6 Things to Do After You File Your S-1
By ICR Healthcare
Oct 10, 2018
News & Press
ICR and Nasdaq Present an Event for Advancing Women Leaders in the Boardroom
By ICR
Oct 9, 2018
News & Press
ICR’s Phil Denning featured in 13D Monitor’s October issue
By Phil Denning
Oct 3, 2018
News & Press
Sponsors Announced for the 2019 ICR Conference
By ICR
Oct 1, 2018
Blog
Turning That Frown Upside Down: How to Handle Negative Reviews Online
By Tim Kane
Sep 20, 2018
Blog
The 4 Biggest Mistakes Executives Make With Analyst Communications
By Caroline Corner, PhD
Sep 19, 2018
Blog
Developing an Annual IR Plan
By Farah Soi & Caitlin Morahan
Sep 14, 2018
News & Press
ICR Expands Healthcare Practice with Addition of Continuum Health
By ICR
Sep 12, 2018
Blog
Will the Hong Kong Exchange Rival NASDAQ For Biotech IPOs?
By ICR Healthcare
Sep 5, 2018
Blog
The Impact of Total Shareholder Return on Proxy Contest Outcomes
By Dan Mcdermott
Aug 23, 2018
Checklist
10 Things Bankers Don’t Tell You About the IPO Road Show
By ICR Healthcare
Aug 22, 2018
Blog
Best Practices in Raising the Profile and Protecting Professional Services Brands
By Christine Hardman and Scott Tangney,
Aug 20, 2018
Blog
Consilium Strategic Communications Acts as PR and IR Advisor to Sensyne Health on Its Successful IPO on London Stock Exchange
By ICR Healthcare
Aug 15, 2018
Blog
An Intro to ESG Research Providers and How to Respond to Their Requests
By Jack Powell- < Previous posts
- 01
- …
- 55
- 56
- 57
- 58
- 59
- …
- 73
- > Next posts